- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
67 Cards in this Set
- Front
- Back
|
What are Iminostilbenes used for
|
generalized and partial seizures and bipolar disorder (mental disorder)
|
|
How do valproic acids exert their pharmacological effect
|
by suppressing sodium and calcium influx and by potentiating GABA
|
|
Valporic Acids are used to treat
|
generalized, partial, and abscence seizures
Bipolar disorder and prophylaxis of migraine HA's |
|
Valporic Acid toxicity
|
moderately hepatoxic
|
|
Succinides pharmacological effect
|
used to treat absence seizures by reducing the synaptic nerve response to low-frequency repetitive stimulation
|
|
What settings are Succinides used
|
clinics only
|
|
Anti-Seizure agents nursing considerations
|
monitor seizure activity, watch for drowsiness when giving sedating agents, monitor therapeutic blood levels, monitor liver enzymes and assess weakness, fatigue and muscle pain
|
|
(Anti-Depressants) What is the basis of depression
|
thought to be a depletion of the neurotransmitters serotonin, dopamine, and norepinephrine
|
|
How does depletion of neurotransmitters during Anti-Depressants occur
|
due to excessive reuptake or by excessive breakdown by monoamine oxidase (MAO)
|
|
Why do clients get discouraged when taking anti-depressants
|
symptoms does not improve for about 4 weeks
|
|
What kind of response does anti-depressants have
|
therapeutic responses vary
|
|
How does anti-seizure meds exert a therapertic effects
|
Anti-seizure agents raise the seizure threshold by inhibiting excitatory activity in the motor cortex of the brain
|
|
(3) Mechanism Anti-seizure drugs exert a therapeutic effect
|
1) suppression of sodium influx,
2) suppression of calcium influx or 3) potentiation of gamma aminobutyric acid (GABA) in the brain |
|
Classificiations of Anti-Seizure Agents
|
Hydantoins
Iminostilbenes Barbituates Benzodiazepines Valporic Acids Succinides |
|
Barbituates agents exert their pharmacological effect by
|
potentiating GABA and decreasing the conduction of impulses
|
|
Barbituates are used for.....and are....
|
seizures and are sedating
|
|
Barbituates use with other drugs
|
may be used in conjunction with other anti-convulsants
|
|
What Benzodiazepines will be used during coma or respiratory depression and how long does it take to work
|
(Romazicon) may be given IV, will work within 2 min.
|
|
Non-Benzodiazepine Somnifacients agents exert their pharmacological effect by
|
potentiating GABA
|
|
Non-Bonzodiazepines effects over Bonzodiazepines
|
have less residual effect and are thought to cause less physiological and psychological dependence
|
|
Non-Benzodiazepine Somnifacients effect on food
|
decrease food bioavailability
|
|
Effect on person if awakened while taking Non-Benzodiazepine Somnifacients
|
short term anesia
|
|
Pharmacological effect of NON-BENZODIAZEPINE ANXIOLYTIC:
buspirone (BuSpar) |
Binds to serotonin and dopamine receptors in the CNS resulting in decreased transmission of these neurotransmitters
|
|
NON-BENZODIAZEPINE ANXIOLYTIC nursing considerations
|
monitor for (EPS) extrapyramidal side effects
abnormal movements, eg. Parkinson dystonia tardive dyskinesia |
|
hormones: melatonin
|
synthesized from serotonin and is secreted by the pineal gland
|
|
melantonin secretions is stimulated by
|
darkness and suppressed by light received through the retina
|
|
hormones: melatonin nursing considerations
|
act very rapidly
decreases food bioavailability short-term amnesia i awakened alcohol increase action causing psycho-motor impairments |
|
DRUGS USED FOR PAIN MANAGEMENT (Analgesics
|
opiods
|
|
Opiods pharmacological effects
|
bind with opiate receptors in the central nervous system altering the perception of and the emotional response to pain
|
|
besides reducing pain opiods.....
|
can be used to suppress cough, slow respiratory rate and decrease peristalsis, pre-medication before surgery
|
|
Analgesia is more effective if
|
given before the pain becomes severe
|
|
best way to manage chronic pain
|
Chronic pain is better managed by scheduled doses around the clock rather than by PRN administration
|
|
Effect when meperidine is given with MAOI's
|
hyperpyrexia
|
|
Assessment of pain includes
|
location,
intensity (use intensity scale) quality pattern precipitating factors alleviating factors associated symptoms coping mechanisms |
|
Opioid Agonists/Antagonists: are thought to have _____addiction potential because________.
|
a lower addiction potential because of their antagonistic properties
|
|
Opioid Agonists/Antagonists are________ likely to cause respiratory depression
|
less likely to cause respiratory depression
|
|
Opioid Agonists/Antagonists cause___________if given to a client who is _______.
|
withdrawal symptoms, opiod dependent
|
|
Opiods Nursing Considerations
|
shouldnt be given in head trauma(can mask symptoms)
shouldnt be given in shock (decrease BP) shouldnt be given in respiratory depression use caution in clients with history of addition (dont deny pain control) use cautiously in pt with urinary retention/asthma cause constipation dont crush SR preparations-respiratory distress |
|
Opioid Antagonists are used
|
for opioid overdoses
|
|
compete with opiates for binding sites
|
Opioid Antagonists
|
|
used to relieve anxiety
|
anxiolytics and somnifacients
|
|
produce sedation before surgeries and procedures and to induce sleep, not an analgesic
|
anxiolytics and somnifacients
|
|
DRUGS USED TO TREAT ANXIETY AND SLEEP DISORDERS
|
anxiolytic and somnifacients
|
|
can be used as adjuncts to analgesia
|
anxiolytic and somnifacients
|
|
Hydantonins pharmacological effects
|
decrease excitability in the motor cortex of the brain by suppressing sodium influx through the sodium channels
|
|
hydantoins
|
decreases the neuronal action potential
highly protein bound narrow therapeutic index hepatoxic |
|
Classifications of Anti-Depressants
|
(TCA's) Tricyclic Anti-Depressants
(MAOI's) Monamine Oxidase Inhibitors (SSRI's) Selective Serotonin Reuptake Inhibitors |
|
TCA's pharmacological effect
|
reuptake of serotonin 5HT and norepinephrine by the pre-synaptic region
|
|
Problems associated with TCA's
|
1) sedation 2) lowered seizure threshold 3) heart block with large doses 4) orthostatic hypotension 5) anti-cholinergic effects 6) increased appetite with weight gain and 7) inorgasmia.
|
|
best time to take TCA's
|
at bedtime
|
|
SSRI's
|
increase the level of serotonin in the brain by decreasing presynaptic neuronal reuptake
|
|
have fewer side effects
|
SSRI's
|
|
SSRI's side efects
|
loss of appetite and decrease sexual function
|
|
Anti-Depressant therapeutic effects seen in
|
4-6 weeks
|
|
Anti- Depressant therapy is seen within
|
should be seen at least 6 months to 1 year
|
|
Nursing Considerations for Anti-Depressants
|
4-6 weeks to see effects
therapy is 6 months -1year increase suicidal ideation in teenagers avoid taking meds with grapefruit and grapefruit juice |
|
Anti Manic agents are used for
|
bipolar disorder by blocking release of dopamine and norepinephrine
|
|
Anti-Manic's
|
has a very narrow therapeutic index
fluid intake of 2500-3500 per day adequate NA intake |
|
Anti-Manic pregnancy category
|
D
|
|
Benzodiazepines pharmacologial effects
|
CNS depression by potentiating GABA and inhibiting impulses subcortically in the limbic system, thalamus and hypothalamus
|
|
3 types of Non-Opiods
|
NSAIDS
Acetaminophen Salicytes |
|
used as adjuncts for chronic pain, raise pain threshold
|
anti-depressants & anti-convulsants
|
|
Parkinson’s disease
|
a degenerative disorder of the CNS caused by the destruction of the neurons in the substantia nigra that produce the neurotransmitter dopamine
|
|
neurons during Parkinson's Disease controls
|
balance, posture and involuntary muscle movement
|
|
Why is dopamine used in Parkinson's Disease
|
Dopaminergic drugs are used to increase dopamine levels
|
|
Parkinson's disease dopamenergic nursing considerations
|
1. Administer anti-Parkinson medications on time to avoid a worsening of symptoms.
2. Abrupt discontinuation of these drugs can lead to a Parkinsonian crisis. 3. Foods high in pyridoxine (vitamin B6) can decrease the effects of these drugs. 4. Change positions slowly to avoid faintness or dizziness. |
|
Parkinson's disease nursing considerations
|
1. Monitor for anti-cholinergic effects such as blurred vision, dry mouth, urinary retention, constipation and tachycardia
|